An Ebola Drug Trial Ended Early Because It Was So Successful. That Could Change How Doctors Handle Future Outbreaks
A year into an Ebola outbreak in the Democratic Republic of the Congo (DRC), researchers have halted an experimental drug trial there because early results appear so promising. The drugs will be made available to more patients in the DRC, hopefully saving lives as the current outbreak continues. But the decision to end the trial … Read more